Investing Profile

Anders Hove

VCFounderInvestor

Partner and Founder at Acorn Bioventures

acornbioventures.comNew York, New York
Photo of Anders Hove, Partner at Acorn Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
INSEAD Network
41 CONNECTIONS
Venrock Network
21 CONNECTIONS
cb
Acorn Bioventures Partner
$100K - $10.0M
$1M
20
CompanyStageDateRound SizeTotal Raised
Intuity Medical
Venture RoundNov 2016$40M
Venture RoundJan 2014$5.5M
Venture RoundAug 2012$12M
Series DAug 2011$12M
Series DJan 2010$64M
$183.5M
Co-investors: Eric Aguiar (Aisling Capital), Casey Tansey (USVP), Scott Bluestein (Hercules Capital)
Edge Therapeutics
Series CApr 2015$56M
$56M
Mevion Medical Systems
Private Equity RoundAug 2014$200M
Private Equity RoundJun 2013$55M
Venture RoundJan 2012$45M
Series COct 2007$6.9M
$306.9M
Coherus Biosciences
Series CMay 2014$54.7M
$54.7M
Virdante Pharmaceuticals
Series ANov 2009$30M
$30M
Anacor Pharmaceutical
Series EJan 2009$50M
Series CMay 2005$25M
$75M
PEAK Surgical
Series CFeb 2008$21M
Series BSep 2006$8M
$29M
Adnexus
Series CAug 2007$15.5M
Series BJun 2006$27M
$42.5M
Co-investors: Alan Crane (Polaris Partners), Noubar Afeyan (Flagship Ventures)
Managing General Partner Venrock2004 - 2016
Portfolio manager of BB Biotech & CEO of Bellevue Asset Management Bellevue Asset Management1996 - 2003
Project Manager Novartis1992 - 1996
INSEAD Master of Business Administration (MBA) Finance, General
Københavns Universitet Doctor of Medicine (M.D.) Biology, General
Danmarks Tekniske Universitet Master of Science (MSc) Biotechnology